NCT02009982View on ClinicalTrials.gov

Cardioneuroablation for Neurocardiogenic Syncope

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Neurocardiogenic SyncopeVasovagal Syncope
Interventions
PROCEDURE

Cardioneuroablation

Catheter Ablation of Vagal Inputs in Left Atrium

DEVICE

Biosense Webster Navistar ThermoCool Diagnostic/Ablation Deflectable Tip Catheter

This is the device that will be used to perform the Cardioneuroablation procedure

Trial Locations (2)

27599

University of North Carolina, Chapel Hill

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

lead

David B. De Lurgio

OTHER

NCT02009982 - Cardioneuroablation for Neurocardiogenic Syncope | Biotech Hunter | Biotech Hunter